Jim Simons Nautilus Biotechnology, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 300,456 shares of NAUT stock, worth $222,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300,456

Previous 250,221 20.08%

Holding current value

$222,337

Previous $420,000 38.57%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.86 - $2.04 $43,202 - $102,479	50,235 Added 20.08%	300,456 $258,000
Q4 2024 Feb 13, 2025	BUY	$1.67 - $2.96 $159,520 - $282,742	95,521 Added 61.75%	250,221 $420,000
Q3 2024 Nov 13, 2024	BUY	$2.24 - $3.08 $32,704 - $44,968	14,600 Added 10.42%	154,700 $440,000
Q2 2024 Aug 09, 2024	BUY	$2.22 - $3.0 $31,302 - $42,300	14,100 Added 11.19%	140,100 $327,000
Q1 2024 May 13, 2024	BUY	$2.41 - $3.18 $22,413 - $29,574	9,300 Added 7.97%	126,000 $370,000
Q4 2023 Feb 13, 2024	SELL	$2.34 - $3.39 $234 - $339	-100 Reduced 0.09%	116,700 $349,000
Q3 2023 Nov 14, 2023	BUY	$2.87 - $3.94 $1,148 - $1,576	400 Added 0.34%	116,800 $369,000
Q2 2023 Aug 11, 2023	BUY	$2.21 - $4.52 $13,702 - $28,023	6,200 Added 5.63%	116,400 $450,000
Q1 2023 May 12, 2023	BUY	$1.67 - $2.77 $17,869 - $29,639	10,700 Added 10.75%	110,200 $305,000
Q4 2022 Feb 13, 2023	BUY	$1.55 - $2.47 $16,120 - $25,688	10,400 Added 11.67%	99,500 $179,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.13 $49,980 - $79,815	25,500 Added 40.09%	89,100 $189,000
Q2 2022 Aug 12, 2022	BUY	$2.64 - $4.84 $138,864 - $254,584	52,600 Added 478.18%	63,600 $171,000
Q1 2022 May 13, 2022	BUY	$3.5 - $5.3 $38,500 - $58,300	11,000 New	11,000 $48,000

Others Institutions Holding NAUT

# of Institutions

Shares Held

63.9M

Call Options Held

28.5K

Put Options Held

View Full List

About Nautilus Biotechnology, Inc.

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $92.3M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

More about NAUT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account